Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

SELL
$8.34 - $14.69 $175,974 - $309,959
-21,100 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$13.6 - $24.89 $36,720 - $67,203
2,700 Added 14.67%
21,100 $300,000
Q3 2021

Oct 21, 2021

BUY
$21.22 - $25.7 $31,830 - $38,550
1,500 Added 8.88%
18,400 $427,000
Q2 2021

Aug 13, 2021

BUY
$22.86 - $30.95 $386,334 - $523,055
16,900 New
16,900 $421,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.